Drug prices in Morocco: reduced from 10 to 70% for 300 drugs

The competent authorities in Morocco decided to adopt the first regulation to reduce the prices of about 300 medicines by rates ranging from 10% to 70% at the point of sale to the public, as part of the activation of the Ministry of Health of a new decree reviewing the drug pricing system adopted since 2013. The ministry confirmed that this first wave will be followed by additional reductions in the coming months, provided that the names of the medicines concerned are officially announced after the publication of the new pricing network, in a step awaited by large segments of Moroccan patients who bear a heavy pharmaceutical bill annually. What does Decree No. 2.25.631 change? Decree No. 2.25.631 was issued on July 23, 2026, and published in the Official Gazette on August 6 of the same year. The text aims to accelerate the pace of reviewing the prices of medicines and bring them closer to the prices approved in the reference countries, in addition to obliging the review of the prices of all currently marketed medicines within 12 months of the entry into force of the decree. The most important changes in the drug pricing system in Morocco Article The previous system (since 2013) The new system (Decree 2.25.631) Periodicity of price review Every 5 years, every 3 years, medicines at a price exceeding 300 dirhams at the factory (without fees), the average prices of the reference countries, the lowest price approved in the reference countries, medicines at 300 dirhams or less, the average prices of the reference countries, the adoption of the same average continues, savings exceeding one billion dirhams, according to the data of the Ministry of Health. This reform is expected to achieve total savings exceeding one billion dirhams, of which about 250 million dirhams will be directly reflected on reducing what patients pay out of their own pockets, a category that includes especially infected patients With chronic diseases, they bear the costs of long-term and recurrent treatment on a monthly basis. Why does this file matter to Moroccans? This reduction comes at a time when the compulsory health insurance system (AMO) and many Moroccan families are bearing escalating burdens for the costs of medicines, especially in light of the spread of chronic diseases that require permanent treatment. By reducing the direct pharmaceutical bill, the government is seeking to ease pressure on household budgets and health insurance funds at the same time. The final list of names of the drugs in question will be determined once the The official network of new prices, provided that subsequent waves include additional medicines, as announced by the Ministry.